Tweet
The Business of Genomics: Planning Now to Survive and Thrive
June 20, 2011 | 5:00 - 8:00 pm
Hotel Kabuki, San Francisco, CA
Registration
This dinner short course program features dynamic presentations, elevator pitches, and interactive discussions relevant to both the scientific and business community.
Science and Technology:
Hear from entrepreneurial academics, start-ups and early-stage companies showcasing their genomic-based ventures focused on:
- Molecular diagnostics
- Personalized diagnostics
- Personalized medicine
- Pharmacogenomics
- Consumer genomics
- Preventative medicine
- Drug development
- Clinical trial patient stratification
Who Should Attend:
Academic Entrepreneurs, Principle Investigators (PIs), Start-Up and Early-Stage Company CEOs/CSOs. Decision makers and experts in licensing, alliance management, business development, strategic planning, technology evaluation, technology transfer, and portfolio management. Capital funding firms including venture capitalists, public & private investors, government funding agencies, corporate governance, incubators, and technology transfer centers.
VENTURE CAPITALIST PANEL
A limited number of five-minute elevator pitch presentations to the VC Panel are available. If you are developing genomic based technologies (with an eye to the future) for any of the disciplines listed above, click here to nominate your company.
- Ted Driscoll, Ph.D., Technology Partner, Claremont Creek Ventures
- Rowan Chapman, Partner, Life Science, Mohr Davidow Ventures
- David Hanzel, Ph.D., Partner, X/Seed Capital
- Gino Di Sciullo, Ph.D., Partner, Charter Life Sciences
More information | Register
June 20, 2011 | 5:00 - 8:00 pm
Hotel Kabuki, San Francisco, CA
Registration
This dinner short course program features dynamic presentations, elevator pitches, and interactive discussions relevant to both the scientific and business community.
Science and Technology:
Hear from entrepreneurial academics, start-ups and early-stage companies showcasing their genomic-based ventures focused on:
- Molecular diagnostics
- Personalized diagnostics
- Personalized medicine
- Pharmacogenomics
- Consumer genomics
- Preventative medicine
- Drug development
- Clinical trial patient stratification
Who Should Attend:
Academic Entrepreneurs, Principle Investigators (PIs), Start-Up and Early-Stage Company CEOs/CSOs. Decision makers and experts in licensing, alliance management, business development, strategic planning, technology evaluation, technology transfer, and portfolio management. Capital funding firms including venture capitalists, public & private investors, government funding agencies, corporate governance, incubators, and technology transfer centers.
VENTURE CAPITALIST PANEL
A limited number of five-minute elevator pitch presentations to the VC Panel are available. If you are developing genomic based technologies (with an eye to the future) for any of the disciplines listed above, click here to nominate your company.
- Ted Driscoll, Ph.D., Technology Partner, Claremont Creek Ventures
- Rowan Chapman, Partner, Life Science, Mohr Davidow Ventures
- David Hanzel, Ph.D., Partner, X/Seed Capital
- Gino Di Sciullo, Ph.D., Partner, Charter Life Sciences
More information | Register